Examkin

Soru

Zorluk: OrtaCardiovascular System

A 76-year-old man is evaluated in the emergency department for a sudden onset of severe lightheadedness and confusion that began one hour ago. His wife reports that he briefly lost consciousness before arrival. He has a history of hypertension and osteoarthritis. Current medications include lisinopril and acetaminophen. His temperature is 36.8°C (98.2°F), blood pressure is 82/50 mm Hg, and pulse is 32/min. Physical examination reveals delayed capillary refill and cool extremities. A 12-lead electrocardiogram demonstrates marked sinus bradycardia with no ischemic changes. He remains hypotensive despite an initial rapid infusion of intravenous fluids. Arrange the following management steps in the correct chronological sequence, from the most appropriate immediate intervention to the definitive long-term treatment assuming the underlying etiology is irreversible.

  1. 1Administer a rapid bolus of intravenous atropine
  2. 2Initiate transcutaneous pacing or an intravenous chronotropic infusion
  3. 3Insert a temporary transvenous pacemaker
  4. 4Implant a permanent cardiac pacemaker

Cevap

The correct sequence for managing symptomatic sinus bradycardia is: Intravenous atropine -> Transcutaneous pacing -> Temporary transvenous pacemaker -> Permanent pacemaker.
The management of symptomatic, hemodynamically unstable bradycardia follows a progressive algorithm designed to rapidly restore perfusion while minimizing invasive risks. The initial intervention is intravenous atropine, which reduces vagal tone and increases the sinus rate. If the patient does not respond adequately to atropine, immediate bridging therapy is required with either transcutaneous electrical pacing or an infusion of a chronotropic agent (such as dopamine or epinephrine). Because transcutaneous pacing can be uncomfortable for conscious patients and is less reliable over extended periods, a temporary transvenous pacemaker should be inserted if the patient requires prolonged stabilization or fails non-invasive measures. Finally, once the patient is stabilized and reversible causes (such as medication toxicity or acute ischemia) have been ruled out, the definitive long-term treatment for irreversible symptomatic bradycardia (e.g., sick sinus syndrome) is the implantation of a permanent cardiac pacemaker.

Adım Adım Çözüm

1
Assess for hemodynamic instability caused by the bradyarrhythmia.
The patient exhibits hypotension, altered mental status, and signs of shock.
Hemodynamic instability dictates the need for immediate, sequential resuscitative interventions rather than clinical observation.
2
Administer the first-line medication for unstable sinus bradycardia.
Intravenous atropine is given to block parasympathetic vagal tone.
Atropine is the fastest initial pharmacologic treatment to increase the sinus heart rate and improve cardiac output.
3
Provide bridging therapy if the initial pharmacologic intervention is ineffective.
Transcutaneous pacing or a chronotropic infusion is initiated.
Non-invasive pacing or infusions provide immediate support while preparing for more invasive and reliable measures.
4
Secure stable, reliable pacing in the acute setting.
A temporary transvenous pacemaker is inserted.
Transcutaneous pacing is often uncomfortable and less reliable for prolonged periods, necessitating a transition to transvenous pacing.
5
Provide definitive long-term management.
A permanent pacemaker is implanted.
Because the condition is presumed to be irreversible (e.g., sick sinus syndrome), permanent pacing is required to prevent future syncopal episodes.

Anahtar Kavram

The advanced cardiac life support (ACLS) bradycardia algorithm prioritizes atropine for initial stabilization, followed by transcutaneous pacing or chronotropic infusions for refractory cases, temporary transvenous pacing for prolonged stabilization, and finally a permanent pacemaker for irreversible underlying causes.
Bu soruyu puanla

Konular

Cardiovascular System

Bu konudan daha fazla soru